P.G. Yeole
Pharmacovigilance and all drug safety issues are pertinent for all those whose life is touched by medical intervention(s). Thus the safety alarms and chaos that resulted recurrently, commencing from thalidomide disaster, led to many painstaking initiatives by the regulatory bodies. It has been an attempt by the International Conference on Harmonization (ICH), World Health Organization (WHO) and Uppsala Monitoring Committee (UMC) to make the best of amendments ...